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The gonadotropin-releasing hormone (GnRH) pulsatile pattern is critical for appropriate reg-
ulation of gonadotrope activity but only little is known about the signaling mechanisms by
which gonadotrope cells decode such pulsatile pattern. Here, we review recent lines of
evidence showing that the GnRH receptor (GnRH-R) activates the cyclic AMP (cAMP) path-
way in gonadotrope cells, thus ending a long-lasting controversy. Interestingly, coupling of
GnRH-R to the cAMP pathway as well as induction of nitric oxide synthase 1 (NOS1) or
follistatin through this signaling pathway take place preferentially under high GnRH pul-
satility. The preovulatory surge of GnRH in vivo is indeed associated with an important
increase of pituitary cAMP and NOS1 expression levels, both being markedly inhibited
by treatment with a GnRH antagonist. Altogether, this suggests that due to its atypical
structure and desensitization properties, the GnRH-R may continue to signal through the
cAMP pathway under conditions inducing desensitization for most other receptors. Such a
mechanism may contribute to decode high GnRH pulsatile pattern and enable gonadotrope
cell plasticity during the estrus cycle.
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INTRODUCTION
Reproduction success depends on the coordinated synthesis
and release of several hormones from the hypothalamus–
pituitary–gonadal axis. Mammalian gonadotropin-releasing hor-
mone (known as GnRH 1) mediates brain control of reproductive
activity and, as amajor actor of gonadotrope axis, has received con-
siderable attention. The neurohormone GnRH is a decapeptide
produced by a small number of scattered hypothalamic neurons
whose cell bodies are primarily located in the preoptic area and
basal hypothalamus. GnRH neurons project to the median emi-
nence and secrete GnRH in a pulsatile fashion into the hypophysial
portal vessels through which GnRH is transported to the anterior
pituitary gland. The release of GnRH by hypothalamic neurons
is inﬂuenced by numerous external and internal factors acting
through central nervous pathways. The pattern of pulsatile GnRH
secretion thus varies widely in both males and females depending
on the reproductive status. GnRH acts via its receptor speciﬁ-
cally expressed in gonadotrope cells to stimulate both synthesis
and exocytosis of the two gonadotropins, luteinizing hormone
(LH) and follicle-stimulating hormone (FSH). LH and FSH will
in turn act on the gonads in a coordinated manner to initi-
ate sexual maturation and regulate gonadal steroidogenesis and
gametogenesis in both sexes. Gonadotrope hormones are com-
plex endocrine signals constituted of non-covalently associated
glycoprotein dimers. Each gonadotropin is composed of an alpha
glycoprotein subunit common to LH,FSH, thyrotropin (TSH) and
placental choriogonadotropin (for a few species) and a unique beta
subunit.
The GnRH pulsatile pattern is critical for appropriate regula-
tion of LH and FSH synthesis and secretion. Indeed, intermittent
stimulation in vivo or in vitro that mimics the physiological
pulsatile release of GnRH efﬁciently stimulates the secretion
of gonadotropins. In contrast, a continuous pattern leads to
desensitization of gonadotrope cells and this has been exploited
by clinicians to suppress gonadotropin secretion (Lahlou et al.,
1987). Furthermore, pulsatility of GnRH varies throughout
the ovarian cycle and accounts for the differential secretion
of LH and FSH. At mid-cycle, during proestrus, an abrupt
and massive increase in GnRH pulsatility is responsible for
gonadotropin surge and ovulation. Only little is known about
the signaling mechanisms by which the pituitary gonadotrope
cells decode GnRH pulse pattern. The aim of this article is
to review the current knowledge on GnRH receptor (GnRH-
R) coupling to the cyclic AMP (cAMP) signaling pathway in
order to highlight its potential role in decoding high GnRH
pulsatility.
COUPLING OF THE GnRH RECEPTOR TO THE cAMP
SIGNALING PATHWAY
GnRH binds to a receptor belonging to the G protein-coupled
receptor (GPCR) family with seven transmembrane domains con-
nected by extracellular and intracellular loops. Agonist binding is
mainly associated with a rapid Gq/11-mediated increase in phos-
pholipase Cβ (PLCβ) activity, which will in turn initiate a wide
array of signaling events. Hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) results in the formation of diacylglycerol
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(DAG) and inositol trisphosphate (IP3). Rapid formation of IP3
induces calcium release from intracellular stores and, together
with GnRH-stimulated calcium inﬂux, accounts for calcium
oscillations that trigger gonadotropin exocytosis. Elevation of
calcium also activates the nitric oxide synthase (NOS) cascade
(NOS1/NO/soluble guanylate cyclase), resulting in a rapid increase
of cyclicGMP(cGMP) levels (Naor et al.,1980; Lozach et al.,1998).
GnRH-induced DAG formation activates protein kinase C (PKC)
isoforms belonging to the three known families of PKC (conven-
tional, novel, and atypical), which mediate notably activation of
mitogen-activated protein kinases (MAPK) cascades. PKC and
MAPK signaling are crucial for the regulation of gonadotropin
subunit gene expression (Thackray et al., 2009). Following a short
time lag, GnRH also activates phospholipase D (PLD) and phos-
pholipase A2 (PLA2). PKC favors the coupling of GnRH-R to
PLD leading to a sustained second wave of DAG that may con-
tribute to maintain PKC activation during prolonged stimulation
by GnRH (Zheng et al., 1994). GnRH-mediated PLA2 activation
generates arachidonic acid and its lipoxygenase products that
have been implicated in GnRH-induced gonadotropin synthe-
sis and release (Naor, 2009). The GnRH-R thus activates a wide
array of signaling entities to regulate gonadotropin synthesis and
release.
It has been clearly established that the cAMP/protein kinase
A (PKA) pathway is essential for gonadotrope function. Indeed,
cAMP analogs mimic most of the effects of GnRH as they
enhance the release of newly synthesized LH and the expres-
sion of several key genes including those encoding LHβ and
α subunits as well as GnRH-R and NOS1 (Starzec et al., 1989;
Garrel et al., 2002; Horton and Halvorson, 2004). However, the
ability of GnRH to induce cAMP production in gonadotrope
cells as well as the involvement of cAMP in GnRH action has
long remained debated. Early observation of Borgeat et al. (1975)
showed that a prolonged exposure (3 h) of rat hemipituitaries to
GnRH stimulates cAMP accumulation and this observation was
conﬁrmed soon after by others (Naor et al., 1975). Since then,
studies performed on dispersed rat pituitary cell cultures did
not evidence any cAMP production or stimulation of adenylyl-
cyclase (AC) activity in response to GnRH (Theoleyre et al.,
1976; Conn et al., 1979). In 1989, the pituitary AC-activating
polypeptide (PACAP) was discovered based on its ability to
strongly activate AC in rat pituitary cells (Miyata et al., 1989).
This probably contributed to lower the interest paid to GnRH-R
signaling through the cAMP pathway. Furthermore, no GnRH-
induced cAMP production could be substantiated on the ﬁrst
gonadotrope cell line that was established in the same period of
time, the αT3-1 cell line (Horn et al., 1991). Accordingly, using
photolabeling experiments, Grosse et al. (2000) argued for the
exclusive coupling of GnRH-R to Gαq/11 in αT3-1 cells. Up to
the early 2000s, the coupling of GnRH-R to the cAMP path-
way in gonadotrope cells thus remained elusive. The ability of
the mammalian GnRH-R to stimulate the cAMP pathway was
however reported in several heterologous systems such as GH3,
COS-7, or HeLa cells (Arora et al., 1998; Lin et al., 1998; Oh
et al., 2005), thus reinforcing the interest for such coupling. The
key to moving forward was the development of novel mod-
els and technologies. The ability of GnRH to induce cAMP
accumulation in gonadotrope cells was demonstrated by two dif-
ferent groups including ours (Liu et al., 2002; Lariviere et al.,
2007) using the gonadotrope cell line LβT2, which is more
fully differentiated than the αT3-1 cell line. cAMP accumulation
was evidenced by biochemical and enzyme-linked immunosor-
bent assays (ELISAs) and was speciﬁcally induced by GnRH-R
activation as shown by competition with a GnRH antagonist.
Further analysis revealed that different mechanisms contribute
to GnRH-R-induced cAMP accumulation. Indeed, based on
photolabeling experiments and on cell-permeable peptides that
uncouple the receptor from Gαs, it was shown that GnRH-
R activates cAMP production via Gs recruitment (Liu et al.,
2002). Additionally, we demonstrated, using selective pharma-
cological inhibitors as well as dominant negative mutants of
PKC isoforms, that novel PKCδ and ε mediate GnRH-R acti-
vation of the cAMP pathway (Lariviere et al., 2007). In both
studies, GnRH-induced increase in cAMP levels exhibited atyp-
ical features. Indeed, GnRH-induced maximal accumulation of
cAMP levels was observed only after a lag of time of approx-
imately 30 min and was delayed as compared to response to
PACAP (Lariviere et al., 2007) or to the beta-adrenergic receptor
agonist, isoproterenol (J. Cohen-Tannoudji, personal communi-
cation). Furthermore, maximal cAMP accumulation was weaker
and this may explain why GnRH-R coupling to this signaling
pathway has long remained controversial. This prompted us to
reevaluate the coupling of GnRH-R to the cAMP signaling path-
way in αT3-1 cells using a recently developed technology. As
reported previously by Horn et al. (1991), we did not detect
any signiﬁcant increase in cAMP levels by ELISAs when cells
were challenged with a GnRH agonist in contrast to response
to PACAP or forskolin stimulation. We then took advantage of
a sensitive technology based on the use of a cAMP biosensor
(pGloSensorTM-22F cAMP Plasmid). αT3-1 cells were transfected
with a plasmid encoding an engineered cAMP sensitive luciferase,
which becomes active upon cAMP binding. Transfected cells were
challenged with a GnRH agonist and the luminescence intensity
was measured in real time in living cells. This strategy allowed
us to demonstrate for the ﬁrst time that GnRH-R couples to
the cAMP pathway in αT3-1 cells (Avet et al., 2012). Indeed,
GnRH dose-dependently increased luciferase activity reﬂecting
cAMP production with an EC50 in the range of 1 nM and the
increase was signiﬁcantly inhibited by co-incubation with the
GnRH antagonist, antide. Once the ability of GnRH to stimu-
late cAMP production was established in both gonadotrope cell
lines, our efforts turned toward trying to understand whether
this could also occurred in native gonadotrope cells. A mas-
sive pituitary cAMP level increase has been reported long ago
to occur during the proestrus afternoon of the rat estrus cycle,
coincidently with the GnRH preovulatory surge (Kimura et al.,
1980). However, despite such temporal coincidence, the precise
contribution of GnRH has never been elucidated. We reevalu-
ated this contribution in vivo by administrating a potent GnRH
antagonist, the ganirelix, to females at the evening of the
diestrus II (Garrel et al., 2010). The marked decrease in pitu-
itary cAMP levels provided evidence for a predominant role
of GnRH in mediating the proestrus-speciﬁc rise of cAMP
(Figure 1).
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FIGURE 1 | Profiles of serum LH and pituitary cAMP and NOS1 levels
during the proestrus and following administration of a GnRH antagonist.
(A) Serum LH, pituitary cAMP, and pituitary NOS1 levels were determined
by radioimmunoassay, ELISA, and western blot analysis, respectively.
(B) Effect of an in vivo treatment with the GnRH antagonist, antarelix.
aP < 0.05 and bP < 0.01 compared with proestrus, **P < 0.01 compared
with diestrus II. Modiﬁed from Kimura et al. (1980), Lozach et al. (1998), and
Garrel et al. (2010).
THE ATYPICAL STRUCTURE OF GnRH RECEPTOR IS
ASSOCIATED WITH RESISTANCE TO RAPID
DESENSITIZATION
All mammalian pituitary GnRH-R (named type I GnRH-R)
exhibit a striking structural feature, which is the lack of a cytoplas-
mic carboxyl-terminal tail. This carboxyl-terminal tail is present
in all other GPCR including GnRH-R from non-mammalian
vertebrates and is a target for kinases such as GRK (GPCR
kinase). GRK-mediated phosphorylation promotes the binding
of β-arrestins, which not only uncouple receptors from G pro-
teins resulting in desensitization but also target many GPCR
for internalization in clathrin-coated vesicles (Ferguson, 2001).
Given the unique absence of cytoplasmic carboxyl-terminal tail,
the initial rate of inositol phosphate accumulation is linear
upon 10 min of GnRH stimulation showing that GnRH-R is
resistance to rapid desensitization (Davidson et al., 1994). Accord-
ingly, mammalian GnRH-R is not phosphorylated upon agonist
stimulation and does not recruit β-arrestins, in contrast to non-
mammalian GnRH-R (Willars et al., 1999; McArdle et al., 2002).
Extensive analysis of GnRH-R internalization has been performed
using biochemical approaches and ﬂuorescent or radiolabeled
GnRH in gonadotrope and heterologous cells. These studies
indicated that mammalian GnRH-R is poorly internalized as
compared to non-mammalian GnRH-R and that addition of
a functional intracellular carboxyl-terminal tail to the receptor
signiﬁcantly increased internalization rates and rapid desensi-
tization. Whereas these studies were rather measuring ligand
internalization, investigations conducted by Millar’s group, using
an epitope-tagged receptor allowed to trace the receptor itself.
These studies established that GnRH-R exhibits a low level of
constitutive internalization and does not undergo rapid agonist-
dependent internalization as compared tonon-mammalianGnRH
or theTSH-releasing hormone receptors (Pawson et al., 2008). The
refractory state of gonadotrope cells under a sustainedGnRHchal-
lenge is thus believed to occur through desensitization mechanism
affecting downstream signaling entities such as Gαq/11, PKC iso-
forms, or IP3 receptors (Willars et al., 2001; Liu et al., 2003) rather
than the receptor itself. Consequently, mammalian GnRH-R has
the unique property amongst GPCR to face prolonged activation
by its ligand.
MECHANISMS CONTRIBUTING TO GnRH-R COUPLING TO
THE cAMP PATHWAY
One intriguing property of GnRH-R coupling to the cAMP path-
way in LβT2 cells is that it appears to be dependent on GnRH
stimulation pattern. We, indeed, observed that an intermittent
stimulation of cells with GnRH, known to stimulate calcium
release or MAPK activation, was ineffective in inducing cAMP
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accumulation (Lariviere et al., 2007). Levels of cAMP were sig-
niﬁcantly increased only under sustained stimulation of GnRH-R
suggesting that this pathway may be preferentially recruited under
high frequency of GnRH pulses, in agreement with the proestrus-
speciﬁc elevation of pituitary cAMP levels during rat ovarian cycle
(Kimura et al., 1980; Garrel et al., 2010). This shows that GnRH-R
maintains cAMP pathway activation under stimulations inducing
desensitization of most GPCR. This atypical feature was recently
conﬁrmed using ﬂuorescence resonance energy transfer reporters
in LβT2 cells in which high pulse frequency of GnRH desensitized
DAG and calcium but not cAMP activation (Tsutsumi et al., 2010).
Only few genes regulated by GnRH through the cAMP/PKA
signaling pathway have been identiﬁed so far. Among them are
those encoding follistatin, Nur77, PACAP, and NOS1 (Winters
et al., 2007; Hamid et al., 2008; Grafer et al., 2009; Mutiara et al.,
2009; Garrel et al., 2010). Interestingly, analysis of how GnRH
regulates two of these genes has revealed that they are prefer-
entially induced under high GnRH pulse frequency. Follistatin
transcript and protein are increased by GnRH administered con-
tinuously or at fast frequency pulses either in vivo in rat or in
a perifused pituitary cells (Besecke et al., 1996) and not at slow
GnRH pulse frequencies. Because follistatin binds to and neu-
tralizes activin, stimulation of FSHβ by GnRH, which requires
activin is blocked. This is believed to explain why expression of
FSHβ is preferentially stimulated under low frequency of GnRH
pulses. In rat anterior pituitary gland, NOS1 is expressed specif-
ically in gonadotrope and folliculostellate cells. Our group has
demonstrated from experiments performed in vivo in rats and
in vitro that NOS1 expression is regulated by GnRH through the
cAMP pathway (Garrel et al., 1998; Lozach et al., 1998). This was
shown in particular by taking advantage of a cell-permeant PKA
inhibitor (PKI) peptide delivery in primary cultures of rat pituitary
cells (Garrel et al., 2010). Interestingly, we observed that NOS1
is preferentially induced by prolonged GnRH treatment. Indeed,
NOS1 expression remained at high levels for at least 48 h after
treatment of rats with a long-lasting GnRH agonist, whereas, at
the same time, LH and FSH secretion was desensitized. Accord-
ingly, we demonstrated in perifused rat pituitary cells that NOS1
is not induced by GnRH delivered at a frequency of one pulse
per hour, although this frequency is able to trigger a massive LH
release. In contrast, NOS1 was maximally induced by a continu-
ous GnRH stimulation, which suppressed gonadotropin release.
Such a result is in agreement with in vivo data showing a marked
increase of NOS1 expression at proestrus during the preovula-
tory GnRH surge, which is characterized by a very high GnRH
pulse frequency (Lozach et al., 1998; Figure 1). Interestingly, treat-
ment with the GnRH antagonist ganirelix not only blocked the
proestrus-speciﬁc cAMP increase (see above) but also signiﬁ-
cantly reduced the rise of NOS1 expression levels (Garrel et al.,
2010; Figure 1) further supporting the physiological relevance
of GnRH-R coupling to the cAMP pathway. Altogether, experi-
ments reported here, suggest that under conditions of high GnRH
pulsatility, GnRH-R,which is atypically maintained at the cell sur-
face, still interacts with its intracellular machinery and activates
the cAMP/PKA pathway. This initiates the expression of a new set
of target proteins among which are NOS1 and follistatin. The role
of GnRH-dependent NOS1 induction at proestrus remains to be
determined. The speciﬁc increase of NOS1 expression leads to a
concomitant huge increase of pituitary cGMP levels at proestrus
(Lozach et al., 1998). cGMP may regulate some cyclic nucleotide-
gated channels thatwehave characterized inpituitary gonadotrope
cells (J. Cohen-Tannoudji, personal communication) and this is
under investigation.
How is the preferential coupling of GnRH-R to the cAMP
pathway selected? This question is still unresolved. GnRH-R is
constitutively localized in low-density membrane microdomains
such as rafts (Navratil et al., 2003). Intense stimulation by GnRH
may alter the signaling platform associated with GnRH-R in rafts
and hence favor receptor coupling to the cAMP pathway. Another
potential mechanism may be related to GPCR-interacting proteins
(GIP) that interact through receptor intracellular domains to reg-
ulate signaling efﬁcacy and speciﬁcity (Bockaert et al., 2004). The
idea that GIP regulate GnRH-R signaling is suggested by the fact
that introduction in αT3-1 cells of synthetic peptides correspond-
ing to intracellular domains of mammalian GnRH-R increases
GnRH-R coupling to the inositol phosphate pathway (Shacham
et al., 2005). We very recently identiﬁed a protein, the protein SET,
as the ﬁrst direct interacting partner of GnRH-R. Using cAMP
and calcium biosensors in αT3-1 living cells combined with small
interfering RNA directed against SET, we showed that SET sig-
niﬁcantly enhances GnRH-R coupling to the cAMP pathway. The
mechanisms contributing to SET recruitment and the potential
regulatory roles of SETon gonadotrope function are under current
investigation.
CONCLUSION
An important question in the ﬁeld of reproductive endocrinol-
ogy is to understand how the GnRH pulsatile pattern is decoded
by pituitary gonadotrope cells. Due to its atypical structure and
desensitization properties, GnRH-R and some of its signaling
mechanisms are continuing to respondundermassiveGnRHstim-
ulations. Such stimulations of gonadotrope cells by GnRH thus
do not lead to general cell desensitization since some genes are
induced in response to GnRH at high pulse frequencies. Varia-
tion in GnRH pulse proﬁles may lead to preferential activation of
different signaling networks and there is now evidence that the
cAMP/PKA pathway contributes to the decoding of high GnRH
pulsatility. This emphasizes the unique feature of gonadotrope
cells, which maintain part of their functional response under con-
ditions of stimulation inducing desensitization of most GPCR.
During the ovarian cycle, the GnRH preovulatory surge lasts
much longer than the LH surge (Caraty et al., 2002). Mainte-
nance of some gonadotrope responsiveness while gonadotropins
are no longer secreted may contribute to gonadotrope cell plastic-
ity during the estrus cycle. Identifying the mechanisms directing
the preferential coupling of GnRH-R to the cAMP pathway is
an exciting challenge. Insight into GnRH-R interacting partners
and into the dynamics of their interactions with the receptor
will undoubtedly help to better understand the plasticity of
gonadotrope cell signaling.
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